Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Ultrastructural Pathology
|
February 27, 2008
Primary hepatic myxoid leiomyosarcoma: a case report and review of the literature
Athanasios C Tsiatis, James B Atkinson, J Kelly Wright, et al.
The Journal of Molecular Diagnostics : JMD
|
May 1, 2010
Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications
Athanasios C Tsiatis, Alexis Norris-Kirby, Roy G Rich, et al.
Anticancer Research
|
August 8, 2009
Cyclooxygenase 2 expression in soft tissue leiomyosarcoma
Megan E Herceg, Athanasios C Tsiatis, Jennifer L Halpern, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 28, 2009
Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma
Athanasios C Tsiatis, Megan E Herceg, Vicki L Keedy, et al.
The American Journal of Surgical Pathology
|
October 15, 2011
Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study
Dora Lam-Himlin, Athanasios C Tsiatis, Elizabeth Montgomery, et al.
European Urology
|
October 10, 2017
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease
Stephen K Van Den Eeden, Ruixiao Lu, Nan Zhang, et al.
European Urology
|
December 4, 2014
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen, Inger L Rosner, Timothy C Brand, et al.
The Lancet. Oncology
|
May 17, 2015
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Brian Rini, Audrey Goddard, Dejan Knezevic, et al.
European Urology
|
May 20, 2014
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2021
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE
Andrew Dj Pearson, Steven G DuBois, Vickie Buenger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Ultrastructural Pathology
|
February 27, 2008
Primary hepatic myxoid leiomyosarcoma: a case report and review of the literature
Athanasios C Tsiatis, James B Atkinson, J Kelly Wright, et al.
The Journal of Molecular Diagnostics : JMD
|
May 1, 2010
Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications
Athanasios C Tsiatis, Alexis Norris-Kirby, Roy G Rich, et al.
Anticancer Research
|
August 8, 2009
Cyclooxygenase 2 expression in soft tissue leiomyosarcoma
Megan E Herceg, Athanasios C Tsiatis, Jennifer L Halpern, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 28, 2009
Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma
Athanasios C Tsiatis, Megan E Herceg, Vicki L Keedy, et al.
The American Journal of Surgical Pathology
|
October 15, 2011
Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study
Dora Lam-Himlin, Athanasios C Tsiatis, Elizabeth Montgomery, et al.
European Urology
|
October 10, 2017
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease
Stephen K Van Den Eeden, Ruixiao Lu, Nan Zhang, et al.
European Urology
|
December 4, 2014
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen, Inger L Rosner, Timothy C Brand, et al.
The Lancet. Oncology
|
May 17, 2015
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Brian Rini, Audrey Goddard, Dejan Knezevic, et al.
European Urology
|
May 20, 2014
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2021
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE
Andrew Dj Pearson, Steven G DuBois, Vickie Buenger, et al.
Page
of 2